Filing Details
Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event.
8k filedNASDAQ:ASBP
Aspire Biopharma Holdings, Inc. (ASBP) Reports Material Event to SEC
Filing Details Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event. Market…
Market Context
Aspire Biopharma Holdings, Inc.'s stock currently trades at $6.58 with a market capitalization of $4.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Aspire Biopharma Holdings, Inc.'s stock.
All SEC filings for Aspire Biopharma Holdings, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ASBP Stock Page
Frequently Asked Questions
Where can I read ASBP's SEC filings?
Browse all filings on our ASBP SEC filings page.
What types of SEC filings does Aspire Biopharma Holdings, Inc. file?
Public companies like Aspire Biopharma Holdings, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.